Biodegradable, cationic methacrylamide-based polymers for gene delivery to ovarian cancer cells in mice

Molecular Pharmaceutics

Volumn 5, Issue 2, 2008, Pages 349-357

  De Wolf, Holger K ^a   Luten, Jordy ^a   Snel, Cor J ^a   Storm, Gert ^a   Hennink, Wim E ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Biodegradable; Cytotoxicity; Gene delivery; Gene therapy; Hyaluronic acid; Methacrylamide polymers; Ovarian cancer

Indexed keywords

HYALURONIC ACID; POLY[N (2 HYDROXYPROPYL)METHACRYLAMIDE]; POLYANION; POLYETHYLENEIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES FLUID; BIODEGRADATION; CANCER CELL; CANCER THERAPY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HETEROZYGOTE; IN VITRO GENE TRANSFER; IN VIVO STUDY; INCUBATION TIME; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TUMOR CELL;

ANIMALS; CELL LINE, TUMOR; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; HYALURONIC ACID; METHACRYLATES; MICE; MICE, INBRED BALB C; OVARIAN NEOPLASMS; POLYETHYLENEIMINE; POLYMERS; TRANSFECTION;

EID: 42549156323     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp700108r     Document Type: Article

References (37)

1. Naora, H.; Montell, D. J. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat. Rev. Cancer 2005, 5 (5), 355-66.
2. Nagy, J. A.; Herzberg, K. T.; Dvorak, J. M.; Dvorak, H. F. Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation. Cancer Res. 1993, 53 (11), 2631-43.
3. Wolf, J. K.; Jenkins, A. D. Gene therapy for ovarian cancer (review). Int. J. Oncol. 2002, 21 (3), 461-8.
4. Poulain, L.; Ziller, C.; Muller, C. D.; Erbacher, P.; Bettinger, T.; Rodier, J. F.; Behr, J. P. Ovarian carcinoma cells are effectively transfected by polyethylenimine (PEI) derivatives. Cancer Gene Ther. 2000, 7 (4), 644-52.
5. Louis, M. H.; Dutoit, S.; Denoux, Y.; Erbacher, P.; Deslandes, E.; Behr, J. P.; Gauduchon, P.; Poulain, L. Intraperitoneal linear polyethylenimine (L-PEI)-mediated gene delivery to ovarian carcinoma nodes in mice. Cancer Gene Ther. 2006, 13 (4), 367-74.
6. Verbaan, F. J.; Klouwenberg, P. K.; Van Steenis, J. H.; Snel, C. J.; Boerman, O.; Hennink, W. E.; Storm, G. Application of poly(2-(dimethylamino) ethyl methacrylate)-based polyplexes for gene transfer into human ovarian carcinoma cells. Int. J. Pharm. 2005, 304 (1-2), 185-92.
7. Hamilton, T. C.; Young, R. C.; Louie, K. G.; Behrens, B. C.; Mckoy, W. M.; Grotzinger, K. R.; Ozols, R. F. Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice. Cancer Res. 1984, 44 (11), 5286-90.
8. Van De Wetering, P.; Schuurmans-Nieuwenbroek, N. M.; Hennink, W. E.; Storm, G. Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes. J. Gene Med. 1999, 1 (3), 156-65.
9. Yeo, T. K.; Nagy, J. A.; Yeo, K. T.; Dvorak, H. F.; Toole, B. P. Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells. Am. J. Pathol. 1996, 148 (6), 1733-40.
10. Stanojevic, Z.; Rancic, G.; Radic, S.; Potic-Zecevic, N.; Dordevic, B.; Markovic, M.; Todorovska, I. Pathogenesis of malignant ascites in ovarian cancer patients. Arch. Oncol. 2004, 12 (2), 115-118.
11. Hunter, A. C. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv. Drug Deliv. Rev. 2006, 58 (14), 1523-31.
12. Luten, J.; Akeroyd, N.; Funhoff, A.; Lok, M. C.; Talsma, H.; Hennink, W. E. Methacrylamide polymers with hydrolysis-sensitive cationic side groups as degradable gene carriers. Bioconjuate Chem. 2006, 17 (4), 1077-84.
13. Kursa, M.; Walker, G. F.; Roessler, V.; Ogris, M.; Roedl, W.; Kircheis, R.; Wagner, E. Novel Shielded Transferrin-Polyethylene Glycol-Polyethylenimine/ DNA Complexes for Systemic Tumor-Targeted Gene Transfer. Bioconjugate Chem. 2003, 14 (1), 222-31.
14. Funhoff, A. M.; Van Nostrum, C. F.; Lok, M. C.; Kruijtzer, J. A.; Crommelin, D. J.; Hennink, W. E. Cationic polymethacrylates with covalently linked membrane destabilizing peptides as gene delivery vectors. J. Controlled Release 2005, 101 (1-3), 233-46.
15. Tang, M. X.; Szoka, F. C. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther. 1997, 4 (8), 823-32.
16. De Wolf, H. K.; Luten, J.; Snel, C. J.; Oussoren, C.; Hennink, W. E.; Storm, G. In vivo tumor transfection mediated by polyplexes based on biodegradable poly(DMAEA)-phosphazene. J. Controlled Release 2005, 109 (1-3), 275-87.
17. Scudiero, D. A.; Shoemaker, R. H.; Pauli, K. D.; Monks, A.; Tierney, S.; Nofziger, T. H.; Currens, M. J.; Seniff, D.; Boyd, M. R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988, 48 (17), 4827-33.
18. Veatch, A. L.; Carson, L. F.; Ramakrishnan, S. Phenotypic variations and differential migration of NIH:OVCAR-3 ovarian carcinoma cells isolated from athymic mice. Clin. Exp. Metastasis 1995, 13 (3), 165-72.
19. Aoki, K.; Furuhata, S.; Hatanaka, K.; Maeda, M.; Remy, J. S.; Behr, J. P.; Terada, M.; Yoshida, T. Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity. Gene Ther. 2001, 8 (7), 508-14.
20. Schatzlein, A. G. Non-viral vectors in cancer gene therapy: principles and progress. Anticancer Drugs 2001, 12 (4), 275-304.
21. Funhoff, A. M.; Van Nostrum, C. F.; Janssen, A. P.; Fens, M. H.; Crommelin, D. J.; Hennink, W. E. Polymer side-chain degradation as a tool to control the destabilization of polyplexes. Pharm. Res. 2004, 21 (1), 170-6.
22. Ogris, M.; Steinlein, P.; Kursa, M.; Mechtler, K.; Kircheis, R.; Wagner, E. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther. 1998, 5 (10), 1425-33.
23. Moghimi, S. M.; Symonds, P.; Murray, J. C.; Hunter, A. C.; Debska, G.; Szewczyk, A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol. Ther. 2005, 11 (6), 990-5.
24. Breunig, M.; Lungwitz, U.; Liebl, R.; Fontanari, C.; Klar, J.; Kurtz, A.; Blunk, T.; Goepferich, A. Gene delivery with low molecular weight linear polyethylenimines. J. Gene Med. 2005, 7 (10), 1287-98.
25. Leclerc, G. M.; Boockfor, F. R.; Faught, W. J.; Frawley, L. S. Development of a destabilized firefly luciferase enzyme for measurement of gene expression. Biotechniques 2000,29 (3), 590-1, 594-6, 598 passim.
26. Regnstrom, K.; Ragnarsson, E. G.; Fryknas, M.; Koping-Hoggard, M.; Artursson, P. Gene expression profiles in mouse lung tissue after administration of two cationic polymers used for nonviral gene delivery. Pharm. Res. 2006, 23 (3), 475-82.
27. Shapiro Ledley, T.; Ledley, F. D. Pharmacokinetic considerations in somatic gene therapy. Adv. Drug Deliv. Rev 1998, 30 (1-3), 133-150.
28. Ludtke, J. J.; Sebestyen, M. G.; Wolff, J. A. The effect of cell division on the cellular dynamics of microinjected DNA and dextran. Mol. Ther 2002, 5 (5 Part 1), 579-88.
29. Gebhart, C. L.; Kabanov, A. V. Evaluation of polyplexes as gene transfer agents. J. Controlled Release 2001, 73 (2-3), 401-16.
30. Zaric, V.; Weltin, D.; Erbacher, P.; Remy, J. S.; Behr, J. P.; Stephan, D. Effective polyethylenimine-mediated gene transfer into human endothelial cells. J. Gene Med. 2004, 6 (2), 176-84.
31. Ruponen, M.; Yla-Herttuala, S.; Urtti, A. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochim. Biophys. Acta 1999, 1415 (2), 331-41.
32. Ruponen, M.; Honkakoski, P.; Ronkko, S.; Pelkonen, J.; Tammi, M.; Urtti, A. Extracellular and intracellular barriers in non-viral gene delivery. J. Controlled Release 2003, 93 (2), 213-7.
33. Roboz, J.; Greaves, J.; Silides, D.; Chahinian, A. P.; Holland, J. F. Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma. Cancer Res. 1985, 45 (4), 1850-4.
34. Ruponen, M.; Ronkko, S.; Honkakoski, P.; Pelkonen, J.; Tammi, M.; Urtti, A. Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. J. Biol. Chem. 2001, 276 (36), 33875-80.
35. Weigel, P. H.; Yik, J. H. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors. Biochim. Biophys. Acta 2002, 17572 (2-3), 341-63.
36. Kayastha, S.; Freedman, A. N.; Piver, M. S.; Mukkamalla, J.; Romero-Guittierez, M.; Werness, B. A. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival. Clin. Cancer Res. 1999, 5 (5), 1073-6.
37. Jones, A. T.; Gumbleton, M.; Duncan, R. Understanding endocytic pathways and intracellular trafficking: a prerequisite for effective design of advanced drug delivery systems. Adv. Drug Deliv. Rev. 2003, 55 (11), 1353-7.